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The nail apparatus is constantly exposed to environmental damage. It requires effective immune responses to
combat infection, while avoiding the loss of nail production and regeneration by autoaggressive immunity. By
immunohistology, we deﬁne here previously unknown characteristics of the normal human nail immune system
(NIS). Compared with other regions of nail epithelium, human leukocyte antigen (HLA)-A/B/C expression is prom-
inently downregulated on both keratinocytes and melanocytes of the proximal nail matrix (PNM), whereas HLA-Gþ
is upregulated here. Together with the expression of macrophage migration inhibitory factor in PNM, this may serve
to inhibit an natural killer (NK) cell attack on major histocompatibility complex (MHC) class Ia-negative PNM. PNM
also displays strong immunoreactivity for potent, locally generated immunosuppressants such as transforming
growth factor-b1, a-melanocyte stimulating hormone, insulin-like growth factor-1, and adrenocorticotropic hor-
mone, exhibits unusually few CD1aþ , CD4þ , or CD8þ , NK, and mast cells. Finally, MHC class II and CD209 ex-
pression on CD1aþ cells in and around the PNM is reduced, indicating diminished antigen-presenting capacity.
Thus, the NIS strikingly differs from the skin immune system, but shows intriguing similarities to the hair follicle
immune system, including the establishment of an area of relative immune privilege in the PNM. This nail immune
privilege may offer a relative safeguard against autoimmunity. But, the localized intraepithelial defect of innate and
adaptive immunity in the PNM revealed here also may impede effective anti-infection defense.
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The nail apparatus and its evolutionary ancestors (claws,
hooves) are essential components of the haptile, tactile,
mechanic, defensive, and/or predatory instrumentarium
used by vertebrates, and is particularly exposed to envi-
ronmental damage and infection (de Berker et al, 2001;
Paus and Peker, 2003; Tosti and Piraccini, 2003). In fact,
bacterial and fungal infections of the nail apparatus (par-
onychia, onychomycoses) rank among the more frequently
encountered diseases (Hanno, 2000), and are notoriously
difficult to treat. Also, chronic inflammatory skin diseases
target the nail apparatus, damaging it substantially and of-
ten irreversibly (Hanno, 2000; de Berker et al, 2001; Rock-
well 2001; Tosti et al, 2001; Tosti and Piraccini, 2003). Thus,
the nail apparatus is faced with the dilemma of having to
combine a system of effective anti-infection defenses and
damage repair with safeguards against the loss of nail pro-
duction and regenerating by autoaggressive/destructive
immunity at each part of nail tissue.
As our knowledge of normal nail immunology is still very
poor and fragmentary, it is as yet unknown how the nail
apparatus addresses this dilemma. In normal human nail
apparatus, only the presence of Langerhans cells, the
absence of intracellular adhesion molecule 1 (ICAM-1)
immunoreactivity, and local expression of antimicrobial
peptides (human cathelicidin LL-37) have been reported
so far (Cameli et al, 1994; Picardo et al, 1994; Tosti and
Piraccini, 2003; Dorschner et al, 2004). In the context of
studying inflammatory diseases that affect the nail, large
numbers of Langerhans cells (i.e., CD1aþ cells) and intra-
epithelial T lymphocytes (with a reported T4/T8 ratio of 2:1)
were found, e.g., in the nail matrix of trachyonychia asso-
ciated with alopecia areata (Tosti et al, 1991, 1995). Lichen
planus, one of the best-investigated inflammatory nail dis-
eases, reportedly shows dense lichenoid lymphocytic infil-
trates with apoptosis of keratinocytes (Tosti et al, 1993;
Hanno, 2000).
This lack of detailed information on even basic immuno-
logical characteristics of the normal human nail apparatus
largely results from difficulty in obtaining fresh samples of
uninfected, uninflamed, non-tumor-bearing human nail
Abbreviations: ACTH, adrenocorticotropic hormone; HLA, human
leukocyte antigen; ICAM-1, intracellular adhesion molecule 1; IGF,
insulin-like growth factor; MICA, major histocompatibility complex
class I chain-related gene A; MIF, macrophage migration inhibitory
factor; MSH, melanocyte stimulating hormone; TGF, transforming
growth factor
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apparatus for cryosectioning and immunohistological anal-
ysis. We obtained access to rare cryospecimen of normal,
uninflamed, uninfected human nail apparatus, obtained with
informed consent during elective surgery of three 3-mo-old
infants with polydactyly (Kozin, 2003), who underwent am-
putation of excess digits.
In view of the developmental and biological similarities of
the nail and the pilosebaceous apparatus (Chuong and
Noveen, 1999; Paus and Peker, 2003; Wu et al, 2004), we
were most interested in drawing parallels between the bet-
ter-characterized hair follicle immune system (HIS) (Paus
et al, 1999), in particular, the striking relative immune priv-
ilege of the growing (anagen) hair follicle (Christoph et al,
2000; Paus et al, 2003, 2005; Ito et al, 2004), and the
evolutionarily older nail apparatus.
Results and Discussion
CD4þ or CD8þ T cells are differentially distributed in
and around the nail apparatus In the epithelial tissue
compartments of the infant human nail apparatus, CD4þ
cells were only rarely detected. Interestingly, most of these
few detectable intraepithelial CD4þ cells were located in
the basal layer of the proximal nail fold (PNF) (Fig 1A)
[7.75  0.75 cells per microscopic field (MF)] (Mean  SEM).
Significantly fewer CD4þ T cells were detected in the nail
matrix epithelium (3.33  0.33 cells per MF) (Fig 1B–D).
This highly differential distribution of intraepithelial T cells
in the nail apparatus was mirrored in the nail mesenchyme
(¼dermis of nail tissue): A high density of CD4þ cells was
observed in the dermal mesenchyme in direct vicinity of the
PNF (22.3  1.8 cells per MF) (Fig 1A, C, D), nail bed (Fig
1B), and hyponychium (data not shown). Intradermally lo-
cated T cells focally accumulated in dense cell clusters
around the infantile nail apparatus (Fig 1A, B), This phe-
nomenon is absent in normal human epidermis or dermis
(Curry et al, 2003; Bos, 2005). As in nail epithelium, the
lowest density of CD4þ was found in nail mesenchyme
around nail matrix (7.43  1.17) (po0.01) (Fig 1B–D). There-
fore, nail CD4þ T cells show a rather differential distribution
pattern, with the nail matrix epithelium and its surrounding
mesenchyme displaying the lowest CD4þ T cell density.
Essentially, the same observation was made for CD8þ
cells, even though their total number was substantially low-
er than that of CD4þ T cells (Fig 1E–K). Clusters of CD8þ
cells were not observed in any of the examined nail sections
(Fig 1E–K).
Antigen-presenting capacity of Langerhans cells and
macrophages in/around the nail matrix may be im-
paired Next, we examined Langerhans cells in the human
nail apparatus. As reported before (Tosti and Piraccini,
2003), the localization of Langerhans cells was similar to that
of normal human epidermis in PNF (Fig 1I), nail bed, and
hyponychium (data not shown). CD1aþ cells, however, were
very rare in the proximal nail matrix (PNM) (Fig 1J). This
resembled the extremely low number of CD1aþ cells seen in
human hair follicle matrix (Christoph et al, 2000). Numerous
CD68þ cells (i.e., dermal macrophages) were detected in
the dermal tissue surrounding all parts of the nail epithelium,
with no apparent differences in this distribution (Fig 1L, M).
To assess the ability of Langerhans cells and macroph-
ages to execute their antigen-presenting function via major
histocompatibility complex (MHC) class II expression (Jane-
way et al, 2001; Goldsby et al, 2003; Bos, 2005), double-
immunolabeling for CD1a or CD68 and human leukocyte
antigen (HLA)-DP/DQ/DR was performed. Interestingly, in-
traepithelial Langerhans cells in dorsal nail matrix and der-
mal macrophages surrounding the entire nail matrix showed
absent or very low immunoreactivity for HLA-DP/DQ/DR
(Fig 1J, M).
In contrast, Langerhans cells and macrophages in/
around PNF (Fig 1I, L) showed the expected strong HLA-
DP/DQ/DR immunoreactivity, suggesting these CD1aþ or
CD68þ cells normally perform their well-recognized ‘‘pro-
fessional’’ antigen-presentation functions via MHC class II
(Fig 1K, N).
Even though this remains to be corroborated by functional
studies, this suggests that both dendritic cell populations in
and around the nail matrix are functionally impaired in their
antigen presenting-capacity.
Figure 1
Localization of immune cells in human infantile nail apparatus. (A) High density of CD4þ cells is seen in proximal nail fold (PNF). Accumulated
CD4þ cells are seen in epithelium and mesenchyme (a: high power) that are not observed in normal human skin. (B) CD4þ Tcells are rarely detected
in adjacent proximal nail matrix (PNM) resembling hair bulb. Some cells are also seen in epithelium. (C) The schematic drawing of CD4þ cell
distribution in nail apparatus. The density of CD4þ T cells around the PNM is lower than that in the PNF. (D) Semiquantitative analysis of CD4þ cells
in epithelium and mesenchyme. The density of CD4þ T cells is significantly decreased in PNM [3.33  0.33 cells per microscopic field (MF)]
compared with epithelium of PNF (7.75  0.75 cells per MF) (n¼ 3). (E and F) CD8þ T cells are rarely seen in and around PNF, nail bed, and PNM.
Some CD8þ cells are observed in PNF, although the number of CD8þ cells is less than that of CD4. (G) The schematic drawing of distribution of
CD8þ T cells in nail apparatus. The density of CD8þ T cells is much less than that of CD4þ T cells. (H) Semiquantitative analysis of CD8þ T cells in
mesenchyme. Higher density of CD8þ cells is detected in around PNF compared with around PNF (n¼3 nails). (I) Double staining is demonstrated
using CD1a (red) and major histocompatibility complex (MHC) class II (green) antibodies on PNF. MHC class II (green) positive Langerhans cells
(CD1aþ ) (red) are seen in PNF (I, high power) (yellow). The density of Langerhans cells may be higher in epithelium of PNF and nail bed compared
within matrix. (J) MHC class II negative Langerhans cells (CD1aþ ) are detected in human dorsal nail matrix (red) but not in PNF (J, high power). This
result implicates that Langerhans cells in matrix may be functionally impaired for antigen presentation. (K) Schematic drawing of immunoreactivity on
CD1a (red), MHC class II (green) and double positive cells (yellow). (L) Double staining are demonstrated using CD68 (red) and MHC class II (green)
antibodies on PNF. MHC class IIþ macrophages are seen in PNF (yellow). (M) MHC class II negative macrophages (CD68þ ) are detected in/around
PNM (red). Not only Langerhans cells but also macrophages are functionally impaired to present antigens in/around PNM. (N) Schematic drawing of
immunoreactivity on CD68 (red), MHC class II (green), and double positive cells (yellow). (O) Double-staining is demonstrated using CD209 (red) and
MHC class II (green) antibodies on PNF. (P) CD209 negative MHC class IIþ cells (red) are detected in/around PNM. This suggests that, in the PNM,
the ability of dendritic cells and/or macrophages to activate resting T lymphocytes and/or dendritic cell trafficking may be partially impaired by
insufficient expression of CD209. (Q) The schematic drawing of immunoreactivity on CD209 (red), MHC class II (green), and double positive cells
(yellow). Scale bar: 50 mm, for all pictures.
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Capacity of nail matrix dendritic cells to associate with T
cells via DC-SIGN (CD209) may be impaired Next, we
asked whether dendritic cells around nail matrix also show
defects in expression of the human dendritic cell-specific
adhesion receptor DC-SIGN (CD209), a C-type lectin that is
highly expressed on the cell surface of immature dendritic
cells in peripheral tissues (Geijtenbeek et al, 2000a, b). CD209
plays an important role in establishing the initial contact be-
tween dendritic cells and resting T lymphocytes via interac-
tion with ICAM-3 and in dendritic cell trafficking through
interaction with endothelial ICAM-2 (Geijtenbeek et al,
2000a, b). DC-SIGN is expressed by cells with an immature
dendritic cell phenotype (Soilleux and Coleman, 2001), and
the DC-SIGNþ cells are HLA-DRþ /low (Soilleux and Coleman,
2001). Moreover, DC-SIGNþ cells appear to be negative for
CD1a (Soilleux and Coleman, 2001). Normal skin shows pos-
itive immunostaining for CD1a on dendritic cells within a
DC-SIGN-negative epidermis (Soilleux and Coleman, 2001).
CD1aþ Langerhans cells did not express CD209 (Fig 1J,
M), as reported before (Soilleux and Coleman, 2001). HLA-
DP/DQ/DRþ cells, however, showed strong IR for CD209 in
dermis beneath the PNF (Fig 2R). Compared with dermis
beneath the PNF, in dermis adjacent to dorsal nail matrix,
the signal intensity of MHC class II IR on CD209þ cells was
substantially weaker (Fig 1O). This suggests that, in PNM,
the ability of dendritic cells and/or macrophages to activate
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resting T lymphocytes and/or dendritic cell trafficking may
be partially impaired by insufficient expression of CD209
(compared with the PNF).
Also, if CD209 expression is indeed a marker of dendritic
cell immaturity (Soilleux and Coleman, 2001), it is interesting
to note that surprisingly many of such ‘‘immature’’ CD209þ
/MHC class IIþ cells were detected in the nail mesenchyme
below the PNF (Fig 1Q) and below the nail bed (not shown).
These immunostaining results are summarized in Fig 1Q.
Natural killer (NK) cells and mast cells are unusually
scarce in the vicinity of the nail matrix It is well appre-
ciated that chronic infectious paronychia and periungual
human papilloma virus-induced verrucae are difficult to
treat and therapy-resistant (de Berker et al, 2001; Tosti et al,
2001). This may be related to the apparent defect in pro-
fessional antigen presentation in and around the nail matrix
revealed above (Fig 1J, M). Alternatively, or in addition to
this, NK cells and mast cells, as key cellular mediators of
innate immunity (Janeway et al, 2001; Goldsby et al, 2003;
Maurer et al, 2003; Bos, 2005), may be reduced in number
and/or function in this location.
Using CD56 as a marker for NK cells (Head et al, 1985),
CD56þ cells were detected at low density in human digital
dermis at some distance to the nail apparatus (data not
shown). CD56þ cells, however, were only very rarely de-
tected in the nail mesenchyme immediately adjacent to PNF
(Fig 2A, B, D–F) (5.67  0.41 cells per MF) or nail bed (data
not shown). Interestingly, the number of CD56þ cells further
declined significantly in mesenchyme associated with nail
matrix (1.18  0.32 cells per MF) (po0.01) (Fig 2C, E, F).
This suggests the human nail matrix mesenchyme, espe-
cially around PNM, is only very poorly equipped with
NK cells.
By toluidine blue histochemistry, dermal mast cells were
found at low numbers in vicinity of nail matrix (2.67  0.58
cells per MF) (Fig 2G, H), whereas mast cell density was
significantly higher in dermis adjacent to PNF (7.25  0.85
cells per MF) (po0.01) (Fig 2I–L). This low number of per-
iungual mast cells is in apparent contrast to high density of
mast cells found in mesenchyme surrounding the human
hair matrix (Christoph et al, 2000). Given that mast cells are
important cellular elements of innate immunity (Maurer et al,
2003), this poor equipment of human nail matrix mesen-
chyme with fully differentiated (i.e., Toluidine blueþ ) mast
cells may further compromise the innate immune defense
capacity of this region of nail mesenchyme. The more
distally located, terminally differentiated nail epithelium, in
Figure 2
Distribution of NK cells and mast cells in
human infantile nail apparatus. (A) The number
of CD56þ cells is low but significantly higher
than that of nail matrix. (B) Although the number
of CD56 positive cells is extremely low in nail
tissue, CD56 positive cells are significantly high-
er in proximal nail fold (PNF) than around nail
matrix. (C) CD56þ cells are rarely detected in the
vicinity of proximal nail matrix (PNM). (D) High
power of Fig 3B (PNF). (E) The schematic draw-
ing of CD56þ cell distribution in nail apparatus.
(F) Semiquantitative analysis of CD56þ cells in
mesenchyme. Higher CD56þcells (5.67  0.41
cells per microscopic field (MF)) are detected in
around PNF compared with around nail matrix
(1.18  0.32 cells per MF) (po0.01). (G) Tolui-
dine blue staining shows reddish deposition
(mast cells) in mesenchyme just around PNM.
Lower number of mast cells is seen in the me-
senchyme around the nail matrix compared with
that in PNF. (H) The high power photograph from
Fig 3G. (I) Higher number of mast cells are ob-
served around PNF compared with mesenchyme
just around PNM. (J) High power of Fig 3I. (K) The
schematic drawing of mast cell distribution in
nail apparatus. (L) Semiquantitative analysis of
mast cells in mesenchyme. Higher number of
mast cells is detected in PNF (7.25  0.85 cells
per MF) (po0.01) compared with around nail
matrix (3.00  0.58 cells per MF). Scale bars:
100 mm in (A); 50 mm in (B–D); 25 mm in (G and I);
12.5 mm in (H and J).
1142 ITO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
contrast, may show more satisfactory innate immune de-
fenses, e.g., by production of antimicrobial peptides (Dors-
chner et al, 2004).
MHC class I expression is prominently downregulated
on PNM keratinocytes HLA-A/B/C is expressed on all nu-
cleated cells except for immunoprivileged tissues (e.g.,
brain, cornea, anterior chamber of the eye, testis, liver, fe-
totrophoblast, hamster cheek pouch, and hair matrix) (Head
and Billingham, 1985; Streilein, 1993, 2003; Mellor and
Munn, 2000; Erlebacher, 2001; Niederkorn, 2002; Paus et al,
2003, 2005). As the nail apparatus shares its embryonal and
evolutionary origin as well as many structural and functional
features with the hair follicle (Chuong and Noveen, 1999;
Paus and Peker, 2003; Wu et al, 2004), we explored whether
defined compartments of the nail apparatus also display a
relative down-modulation of MHC class I as a key feature of
immunoprivileged tissue sites (Streilein, 1993, 2003;
Niederkorn, 2002).
Indeed, the nail matrix epithelium, and most prominently
the PNM, displayed downregulated HLA-A/B/C immuno
reactivity (Fig 3A, B, D), compared with PNF (Fig 3A, C, D),
nail bed, and hyponychium (Fig 3A, D). This low or absent
MHC class I expression in nail matrix epithelium was mir-
rored in the immediately adjacent nail mesenchyme (Fig 3A,
D). In contrast, the functionally important MHC class I-as-
sociated molecule, b2-microglobulin, which stabilizes MHC
class I-antigen interactions (Janeway et al, 2001; Bos,
2005), was expressed throughout the human nail apparatus,
even though the most PNM appeared to show slightly lower
b2-microglobulin immunoreactivity than the rest of the nail
epithelium (Fig 3E, F).
PNM melanocytes are MHC class I negative Normal nail
matrix contains melanocytes (Higashi, 1968; Higashi and
Saito, 1969; Hashimoto, 1971; Tosti et al, 1994). As me-
lanocytes of the human pigmentary unit (Tobin and Paus,
2001) show deficient classical MHC class I expression (Mo-
seley et al, 1997, Ito et al, 2004), we investigated the HLA-A/
B/C expression on melanocytes in nail matrix. Melanocytes
in the PNF and nail bed were strongly HLA-A/B/Cþ (Fig 3G,
H). In contrast, PNM melanocytes displayed no HLA-A/B/C
immunoreactivity (Fig 3I). This reflects the situation in the
(MHC class I-negative) human hair follicle matrix (Moseley
et al, 1997; Ito et al, 2004) and further supports the notion
that the human nail matrix is a site of relative immune
privilege.
Comparable with the hair follicle (Paus et al, 2005), lack
of MHC class I expression on nail melanocytes may prevent
attacks by autoreactive CD8þ T cells on melanocyte-asso-
ciated antigens in PNM. Collapse of nail immune privilege
and a concomitant ectopic upregulation of MHC class
Figure 3
The expression of MHC class I and II in
human infantile nail apparatus. (A)
Human leukocyte antigen (HLA)-A/B/C
immunoreactivity is prominently downreg-
ulated on keratinocytes of proximal nail
matrix (PNM). This expression pattern is
very similar to that in hair follicle. (B) HLA-
A/B/C expression on NM. The expression
is weaker than on epithelium of PNF. High
power photographs from Fig 2A. (C) HLA-
A/B/C is strongly expressed on the epi-
thelium of PNF. High power photographs
from Fig 2A. (D) The schematic drawing of
HLA-A/B/C immunoreactivity pattern on
nail. (E and F) b2 microglobulin is moder-
ately expressed both in nail matrix and
PNF. This expression pattern is not paral-
leled with HLA-A/B/C. (G and H) Double
staining is demonstrated using NHC-A/B/
C (red) and NKI/beteb (green) antibodies
on PNF and PNM. Major histocompatibil-
ity complex (MHC) class I (red) positive
melanocytes are seen in PNF (G, high
power) (yellow). HLA-A/B/C protein ex-
pression is prominently down regulated
on NKI/beteb (melanocytes) of PNM com-
pared with that of PNF by TSA (H) (H, high
power). (I) The schematic drawing of MHC
class I immunoreactivity of melanocytes.
(J and K (V–W)) Compared with PNF (J),
HLA-G is strongly expressed in PNM (K).
(L (X)) The schematic drawing of HLA-G
immunoreactivity on nail. Scale bars: 50
mm for all pictures.
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I-expression on nail melanocytes, e.g., in patients with alo-
pecia areata may expose melanocytes to immune recogni-
tion and cytotoxic autoimmune attack (Paus et al, 1994,
2005), thus leading to onychodystrophy/trachyonchia, as it
is frequently associated with alopecia areata (Tosti et al,
1991).
HLA-G is most prominently expressed in the nail ma-
trix In the fetotrophoblast (Table S1: used as positive con-
trol), downregulation of classical MHC class I molecules
(MHC class Ia, i.e., HLA-A/B/C) is paralleled by an upreg-
ulation of non-classical MHC class I molecules (MHC class
Ib), such as HLA-G, which can interact with killer inhibitory
receptors (KIR) on NK cells to downregulate NK and T cell
cytotoxic functions (Pazmany et al, 1996; Rouas-Freiss et al,
1997; Carosella et al, 1999; Janeway et al, 2001). The in-
fantile human nail apparatus indeed expresses MHC class
Ib molecules and that, compared with the PNF (Fig 3J),
HLA-G-like IR is strongly upregulated in PNM (Fig 3K, L).
HLA-G expression plays an important role for establishing
fetal immunotolerance (Weetman, 1999; Fuzzi et al, 2002)
and may rank among the escape strategies of malignant
tumors from immunosurveillance via inhibition of NK cell
functions (Rouas-Freiss et al, 1997; Rjagopalan and Long,
1999; Aractingi et al, 2003). Therefore, HLA-G expression in
PNM may serve to inhibit an attack of NK cells on this HLA-
A/B/C-negative tissue.
NKG2D and major histocompatibility complex class I
chain-related gene A (MICA) are expressed in/around
the nail matrix HLA-A/B/C molecules are ligands for mem-
bers of the KIR expressed on NK cells, whose stimulation
by MHC class I prevents NK cell-mediated lysis of target
cells (Diefenbach et al, 2000). NK cells are thought to
eliminate cells that have lost MHC class I surface expres-
sion because of viral infection or malignant transfor-
mation (Ljunggren and Karre 1990; Goldsby et al, 2003).
Therefore, the loss of MHC class I expression in the
PNM (Fig 3A, B, D) makes it vulnerable to attack by NK
cells. As has previously been reported, however, in other
immunoprivileged tissues (Apte et al, 1998; Christoph et al,
2000), NK cell activity in and around the normal nail
matrix appears to be rather reduced than increased, as
judged by the unusually low number of NK cells detected
here (Fig 2C–F).
Besides the expression of HLA-G, NK cell-activating
systems might be downregulated in and around the PNM so
as to ward off an NK cell attack. Therefore, we studied the
expression of MICA and NKG2D. The MHC-encoded pro-
tein MICA binds to NKG2D as its receptor (Bauer et al,
1999). MICA is expressed on a subset of intestinal epithelial
cells, and is upregulated by many human carcinoma cells
(Table S1: breast carcinoma used as positive control) and
under conditions of stress (Groh et al, 1996, 1999). NK cells,
gdT cells, macrophages, and CD8þ T cells express NKG2D,
and these cells are activated by stimulation with MICA (Ba-
uer et al, 1999).
Within the obvious limits of immunohistology, we could
not detect a defect in this NK-stimulating system in the nail
matrix. On the contrary, whereas the (MHC class Iþ ) PNF
and epidermis both showed only weak MICA expression
(Fig 4A, B), the MHC class I-negative nail matrix displayed
significantly stronger MICA IR (Fig 4C), confirmed by semi-
quantitative immunohistomorphometry (Fig 4D). Further-
more, the MICA receptor, NKG2D, was expressed in the nail
matrix (Fig 4E, F) and on isolated cells in the adjacent me-
senchyme (Fig 4E), which likely reflected NK cells, CD8þ
cells, and/or macrophages (Bauer et al, 1999).
Therefore, the immunoprivileged human nail matrix still
seems to be capable of NK cell activation via the MICA/
NKG2D system. Strong MICA expression in the nail matrix
may help to protect it against viral infection (e.g., human
papilloma virus) and/or malignant epithelial transformation
so as to counter-balance the enhanced susceptibility to viral
infection that comes along with the generation of an area of
immune privilege.
The nail matrix expresses macrophage migration inhib-
itory factor (MIF) Next, we investigated the local expres-
sion of secreted immunosuppressive factors that are
classically associated with areas of relative immune privi-
lege (Streilein 1993, 2003; Niederkorn 2003; Paus et al,
2005). As in ocular immune privilege, MIF inhibits an attack
of NK cells on MHC class Ia-negative corneal cells (Table
S1: used as positive control) (Apte et al, 1998; Niederkorn,
2002, 2003), we also checked MIF expression in the human
nail apparatus.
Here, we show that the entire human nail epithelium ex-
presses MIF-like IR. Compared with the PNF and the ep-
idermis (Fig 4I, J), however, MIF-IR Is upregulated in
the nail matrix (Fig 4K), as confirmed by semiquantitative
immunohistomorphometry (Fig 4L). MIF may inhibit NK cell-
mediated cytotoxicity in PNM by preventing the release of
cytolytic perforin granules from NK cells (Fig 4K) (Apte et al,
1998). Thus, comparable with the anterior eye chamber, MIF
expression (in addition to HLA-G expression) may protect
the nail matrix from NK cell-mediated injury.
PNM expresses potent immunosuppressants Next, we
investigated whether other potent immunosuppressive
agents that are recognized as key mediators of relative im-
mune privilege (Taylor, 1999; Niederkorn, 2003; Paus et al,
2003, 2004; Ito et al, 2004) are expressed locally in the MHC
class I-negative human nail matrix.
Prominent IR for insulin-like growth factor-1 (IGF-1) (Fig
4M), a-melanocyte stimulating hormone (a-MSH) (Fig 4N),
adrenocorticotropic hormone (ACTH) (Fig 4O), transforming
growth factor-b1 (TGF-b1) (Fig 4P) was detected by tyr-
amide signal amplification (TSA) immunofluorescence, most
prominently in the PNM compared with the epithelium be-
side PNF, which show slight IR of these immunosuppressive
molecules (data not shown). Thus, as in ocular and/or hair
follicle immune privilege (Paus et al, 1997, 2003, 2005; Tay-
lor, 1999; Niederkorn, 2003; Ito et al, 2004), TGF-b1, ACTH,
a-MSH, and IGF-1 may join ranks in the PNM of the human
nail apparatus with MIF (Apte, 1998) in order to serve as
‘‘guardians’’ of nail immune privilege.
Nail epithelium does not express ICAM-1 Finally, we ex-
plored the constitutive level of ICAM-1 (CD54) expression in
the human nail apparatus, as ICAM-1 is a key cell adhesion
molecule involved in the upregulation of a wide range of
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pro-inflammatory immune responses (Cameli et al, 1994;
Janeway et al, 2001; Goldsby et al, 2003; Bos, 2005). In
addition, human nail matrix cells reportedly express a low
level of ICAM-1 in vitro (Picardo et al, 1994).
But, in situ, the infantile human nail apparatus does not
show ICAM-1 IR in any epithelial compartment (Fig 4G, H),
and only the expected constitutive ICAM-1 expression on
blood vessels was detected in the periungual mesenchyme
(Fig 4H). Therefore, the reported upregulation of ICAM-1 on
cultured human nail matrix keratinocytes (Picardo et al,
1994) likely represents an experimental artifact, e.g., as
reflection of a wounding response of these keratinocytes
during tissue dissection, cell dissociation, and culture.
Conclusions and Perspectives
Here, we show that the distribution and functional markers
of key protagonists of acquired and innate cutaneous im-
munology differ between the human skin immune system
(SIS) (Bos, 2005) and the nail immune system (NIS) (Table
S2). Namely, number and function of antigen-presenting
Figure 4
The immunoreactivity of NK cell–asso-
ciated molecules and immunosuppres-
sants in human infantile nail apparatus.
(A–C) The epidermis (A) and epithelium of
proximal nail fold (PNF) (B) show the faint
expression of major histocompatibility com-
plex class I chain-related gene A (MICA).
On the other hand, the major histocompat-
ibility complex (MHC) class I-negative nail
matrix displayed significantly stronger
MICA immunoreactivity. (D) The schematic
drawing of MICA expression in nail appa-
ratus. Semiquantitative analysis of MICA in
nail matrix shows significant higher mean
intensity of MICA expression compared
with epithelium of PNF. Mean intensity
is measured by NIH image software. (E)
NKG2D positive cells are infiltrated around
the PNM (F, High power of Fig 4E). (G) in-
tracellular adhesion molecule 1 (ICAM-1)
positive cells are extremely rare in the vi-
cinity of PNM. (H) ICAM-1 positive cells are
easily detected in vascular endothelial cells
in the vicinity of epidermis. (I–K) Compared
with epidermis (I) and PNF (J), nail matrix
substantially expressed macrophage mi-
gration inhibitory factor (MIF) (K). (L) The
schematic drawing of MIF expression in nail
apparatus. Semiquantitative analysis of MIF
in nail matrix shows significant higher ex-
pression of MIF compared with epithelium
of PNF. (M–P) Immunoreactivity of immuno-
suppressant (IGF-1, a-MSH, ACTH, and
TGF-b1) is strongly detected in the PNM.
These immunoreactivities are substantially
stronger than in epithelium of PNF (data not
shown). Scale bars: 50 mm for all pictures.
IGF-1, insulin-like growth factor-1; a-MSH,
a-melanocyte stimulating hormone; ACTH,
adrenocorticotropic hormone; TGF-b1,
transforming growth factor.
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cells are substantially lower in the NIS than in the epidermis
(Fig 1I–N), with a striking downregulation of MHC class II
and CD209 expression by Langerhans cells in the PNM (Fig
1O, P), Also, key protagonists of innate immunity (NK and
mast cells) are found at reduced numbers and/or function
around the human nail apparatus (Fig 2). Furthermore,
whereas MIF and MICA expression has not been described
in normal human epidermis (Fig 4A–D, I–L), these important
regulators of NK cell function are prominently expressed in
the PNM (Fig 4C, K). Most importantly, our data suggest
that the human nail matrix represents a site of relative im-
mune privilege, not only because of the downregulation of
MHC class I expression, and the low number of (functionally
impaired) dendritic cells, but also because of the prominent
expression of potent immunosuppressants (ACTH, a-MSH,
IGF-1, TGF-b1, MIF) (Fig 4M–P).
The normal NIS of humans infants shows intriguing sim-
ilarities to (evolutionarily younger) human HIS (Paus et al,
1997, 2003, 2005; Christoph et al, 2000; Ito et al, 2004)—
namely that HIS and NIS both exhibit defined compart-
ments that represent as the sites of relative immune
privilege (Table S2). For this immune tolerance, immune
privilege is reasonable for infant nail matrix same as adult. If
PNM is significantly attacked, the nail structure will not be
complete, and nail is vulnerable from many kinds of micro-
organism. Our study, however, also reveals important im-
munological differences between the nail apparatus and the
pilosebaceous unit in man (Table S2):
 b2 microglobulin is not detected in the proximal epithe-
lium of human hair follicle (Ito et al, 2004), but is positive
in the PNM (Fig 3E, F).
 In contrast to the strongly MHC class Iþ and b2 micro-
globulinþmesenchyme of the human hair follicle (Christ-
oph et al, 2000; Ito et al, 2004), the nail immune privilege
appears to extend to the periungual mesenchyme, es-
pecially around the PNM, as the latter is also MHC class
I-negative and shows a greatly reduced number of T,
Langerhans, and NK cells (Fig 3A, B, Table S2).
 HLA-G is strongly expressed in the nail matrix (Fig 3K, X),
but has not been reported in human hair matrix and was
also not found by us in sections of normal human scalp
skin (Ito et al, unpublished observations).
The next challenge is to obtain functional evidence that
defined compartments of the nail apparatus really are
immunoprivileged, and to understand which potential ben-
efits may have arisen from the peculiar arrangement of the
NIS. For example, the well-developed immune system of
the more distally located components of the NIS (along with
the expression of antimicrobial peptides here (Dorschner
et al, 2004)) offers reasonable anti-infection defenses.
Hyponychium and PNF are—often forgotten, but clinically
highly relevant—ports of entry for microbial invasion into the
mammalian organism, perhaps best comparable with the
follicular canal (Paus et al, 1999; Christoph et al, 2000; Paus
and Peker, 2003). Therefore, it makes perfect sense that
many more CD1a, CD68þ , or CD4þ cells are stationed
in and around PNF and hyponychium than in the PNM
(Fig 1A–N).
On the other hand, chronic and acute inflammatory nail
disorders because of infection or irritation (maceration,
chemical damage) affect primarily the PNF not the PNM (de
Berker et al, 2001; Rockwell 2001; Mallet, 2002). Therefore,
it is conceivable that the relative immune privilege of the
PNM may serve to suppress inflammatory/autoimmune
damage to the most critical component of the actual ‘‘nail
factory’’ to promote the survival chances of a species by
protecting it from a loss of claws, hooves, or nails because
of pro-inflammatory environmental insults (maceration, trau-
ma, chemical irritation, bacterial and fungal infection), and
to quickly restore the vital use of these skin appendages by
limiting swelling and pain after nail trauma or infection.
Materials and Methods
Tissue specimens Human infantile nail specimens were obtained
from three different healthy male infants with polydactyly (3 mo)
with informed consent from their parents during elective surgery.
Before staining, specimens were embedded and processed for
longitudinal cryosections. Cryosections (8 mm thick) were fixed with
acetone at 201C for immunohistochemistry, and stored at 201C
until use.
Immunohistology Among the primary antibodies listed in Table
S1, antigen-antibody complexes were visualized with the highly
sensitive TSA technique (Perkin Elmer, Boston, Massachusetts)
(Roth et al, 1999) in the indicated cases, following our previously
published TSA protocol (Ito et al, 2004). MICA, NKG2D, and MIF
antigens were stained by the ABC method, using established
protocols (Christoph et al, 2000). CD4, CD8, CD54, CD56, and b2-
microglobulin were localized by the EnVision technique (DAKO,
Hamburg, Germany) (Ito et al, 2004) using the anti-human primary
antibodies indicated in Table S1 because this technique gave
better immunostaining results for these antigens than the TSA
technique.
Cryosections stained with antibody against human CD1a,
CD68, or CD209 by the TSA technique were double stained with
fluorescein isothiocyanate-conjugated antibody against HLA-DP/
DQ/DR (Table S1). Cryosections TSA-stained with antibody against
human NKI/beteb were double stained with rhodamine-conjugated
anti-HLA-A/B/C (Table S1).
All the appropriate positive (Table S1) and negative controls for
each of the used antigens were performed, and the immunostain-
ing results confirmed the specificity and sensitivity of the corre-
sponding immunoreactivity patterns.
Toluidine blue staining In order to localize mast cell in human
nail tissue, toluidine blue staining was applied. Acetone-fixed
cryosections were stained with 1% toluidine blue (MERCK, Dar-
mstadt, Germany) (pH 8.9) for 1 min at room temperature. Mast
cells were detected as red-purple granules (Haas et al, 1995).
Quantitative (immuno-)histomorphometry Positively stained
cells were counted by quantitative (immuno-)histomorphometry in
a blinded fashion following our previously described morphometry
techniques (Paus et al, 1998; Christoph et al, 2000; Ito et al, 2004).
The nail was divided into the nail matrix and the PNF anatomically
as shown, and CD4þ , CD8þ , CD54þ , CD56þ , and mast cells
(toluidine blue staining) in these compartments were counted in
three MF (magnification  250) from one nail (n¼ 3 individuals)
(Student’s t-test). The staining intensity of MICA and MIF was
compared between matrix and PNF using NIH image software
(NIH, Bethesda, Maryland) for semiquantitative analysis (Ito et al,
2004).
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1146 ITO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
informed consent. The medical ethical committee of the University
Hospital Hamburg-Eppendorf approved all described studies.
We are grateful to Dr J.-Z. Qin (Loyola University, Chicago), Prof.
N. Romani/University of Innsbruck, Prof. G. Girolomoni/IDI, Rome for
helpful advice and support, and to S. Wegerich and G. Pillnitz-Stolze
for excellent technical assistance. This study was supported in part
by a grant from Cutech Srl, Padova, to R. P. and NIH grant AR40065
to B. J. N.
Supplementary Material
The following material is available online for this article.
Table S1. The list of antibodies used for immunohistochemical staining
Table S2. Comparison of distribution and immunoreactivity between
SIS, HIS, and NIS
DOI: 10.1111/j.0022-202X.2005.23927.x
Manuscript received September 2, 2004; revised April 29, 2005; ac-
cepted for publication May 14, 2005
Address correspondence to: T. Ito, Department of Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan. Email:
itoutai@hama-med.ac.jp
References
Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY: Role of macrophage
migration inhibitory factor in inhibiting NK cell activity and preserving
immune privilege. J Immunol 160:5693–5696, 1998
Aractingi S, Kanitakis J, Euvrard S, Le Danff C, Carosella ED: Selective expres-
sion of HLA-G in malignant and premalignant skin specimens in kidney
transplant recipients. Int J Cancer 106:232–235, 2003
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T: Activation of NK
cells and Tcells by NKG2D, a receptor for stress-inducible MICA. Science
285:727–729, 1999
Bos JD (ed.): Skin Immune System—Cutaneous Immunology and Clinical
Immunodermatology. Boca Raton: CRC Press, 2005; p 1–494
Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML: The
skin immune system (SIS): Distribution and immunophenotype of lymph-
ocyte subpopulations in normal human skin. J Invest Dermatol 88:569–
573, 1987
Buentke E, Heffler LC, Wilson JL, et al: Natural killer and dendritic cell contact in
lesional atopic dermatitis skin—Malassezia-influenced cell interaction. J
Invest Dermatol 119:850–857, 2002
Cameli N, Picardo M, Tosti A, Perrin C, Pisani A, Ortonne JP: Expression of
integrins in human nail matrix. Br J Dermatol 130:583–588, 1994
Carosella ED, Rouas-Freiss N, Paul P, Dausset J: HLA-G: A tolerance molecule
from the major histocompatibility complex. Immunol Today 20:60–62,
1999
Christoph T, Mu¨ller-Rover S, Audring H, et al: The human hair follicle immune
system: Cellular composition and immune privilege. Br J Dermatol 142:
862–873, 2000
Chuong CM, Noveen A: Phenotypic determination of epithelial appendages:
Genes, developmental pathways, and evolution. J Invest Dermatol Symp
Proc 4:307–311, 1999
Curry JL, Qin JZ, Robinson J, Nickoloff BJ: Reactivity of resident immunocytes in
normal and prepsoriatic skin using an ex vivo skin-explant model system.
Arch Pathol Lab Med 127:289–296, 2003
de Berker DAR, Baran R, Dawber RPR: The nail in dermatological diseases. In:
Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A (eds). Disease
of the Nails and their Management. Oxford: Blackwell Science, 2001;
p 172–222
Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH: Ligands for the
murine NKG2D receptor: Expression by tumor cells and activation of NK
cells and macrophages. Nat Immunol 1:119–126, 2000
Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL: Innate immune def-
ense of the nail unit by antimicrobial peptides. J Am Acad Dermatol
50:343–348, 2004
Erlebacher A: Why isn’t the fetus rejected? Curr Opin Immunol 13:590–593, 2001
Fuzzi B, Rizzo R, Criscuoli L, et al: HLA-G expression in early embryos is a
fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol
32:311–315, 2002
Geijtenbeek TB, Krooshoop DJ, Bleijs DA, et al: DC-SIGN-ICAM-2 interaction
mediates dendritic cell trafficking. Nat Immunol 1:353–357, 2000a
Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van
Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-
specific ICAM-3 receptor that supports primary immune responses. Cell
100:575–585, 2000b
Goldsby RA, Kindt TJ, Osborne BA, Kuby J: Immunology, 5th ed. New York: W.H.
Freeman, 2003
Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T: Cell stress-
regulated human major histocompatibility complex class I gene ex-
pressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93:12445–
12450, 1996
Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-
associated expression and recognition by tumor-derived gdT cells of MI-
CA and MICB. Proc Natl Acad Sci USA 96:6879–6884, 1999
Haas N, Hamann K, Grabbe J, Algermissen B, Czarnetzki BM: Phenotypic char-
acterization of skin lesions in urticaria pigmentosa and mastocytomas.
Arch Dermatol Res 287:242–248, 1995
Hanno R: Inflammatory reactions of the nail. In: Farmer ER, Hood AF (eds). Pa-
thology of the Skin. New York: McGraw-Hill, 2000; p 870–875
Hashimoto K: Ultrastructure of the human toenail. I. Proximal nail matrix. J Invest
Dermatol 56:235–246, 1971
Head JR, Billingham RE: Immunologically privileged sites in transplantation im-
munology and oncology. Perspect Biol Med 29:115–131, 1985
Higashi N: Melanocytes of nail matrix and nail pigmentation. Arch Dermatol
97:570–574, 1968
Higashi N, Saito T: Horizontal distribution of the DOPA-positive melanocytes in
the nail matrix. J Invest Dermatol 53:163–165, 1969
Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R: Collapse and resto-
ration of MHC class I-dependent immune privilege: Exploiting the human
hair follicle as a model. Am J Pathol 164:623–634, 2004
Janeway CA, Travers P, Walport M, Shlomchik M (eds): Immunobiology. New
York: Garland Publishing, 2001
Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED,
Aractingi S: HLA-G expression in atopic dermatitis. J Invest Dermatol
117:750–752, 2001
Kozin SH: Upper-extremity congenital anomalies. J Bone Joint Surg Am 85-
A:1564–1576, 2003
Ljunggren HG, Karre K: In search of the ‘‘missing self’’: MHC molecules and NK
cell recognition. Immunol Today 11:237–244, 1990
Mallet RB: Paronychia. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I
(eds). Treatment of the Skin Disease. Philadelphia: Mosby, 2002;
p 446–448
Maurer M, Theoharides T, Granstein RD, et al: What is the physiological function
of mast cells? Exp Dermatol 12:886–910, 2003
Mellor AL, Munn DH: Immunology at the maternal–fetal interface: Lessons for
T cell tolerance and suppression. Annu Rev Immunol 18:367–391,
2000
Moseley RP, Brown JI, Auld J, et al: An immunocytochemical study of MHC class
I expression on human Langerhans cells and melanocytes. J Pathol 181:
419–425, 1997
Murphy GF: Histology of the skin. In: Elder DE, Elenitsas R, Johnson BL
Jr, Murphy GF (eds). Lever’s Histopathology of the skin. Philadelphia:
Lippincott Williams and Wilkins, 2005; p 9–58
Niederkorn JY: Immunology and immunomodulation of corneal transplantation.
Int Rev Immunol 21:173–196, 2002
Niederkorn JY: Mechanisms of immune privilege in the eye and hair follicle. J
Investig Dermatol Symp Proc 8:168–172, 2003
Paus R: Immunology of the hair follicle. In: Bos JD (ed). Skin Immune System
(SIS): Cutaneous Immunology and Clinical Immunodermatology. Boca
Raton: CRC Press LCL, 1997; p 377–398
Paus R, Christoph T, Mu¨ller-Ro¨ver S: Immunology of the hair follicle: A short
journey into terra incognita. J Invest Dermatol Symp Proc 4:226–234,
1999
Paus R, Ito N, Takigawa M, Ito T: The hair follicle and immune privilege. J Investig
Dermatol Symp Proc 8:188–194, 2003
Paus R, Nickoloff BJ, Ito T: A ‘‘hairy’’ privilege. Trends Immunol 26:32–40, 2005
Paus R, Peker S: Biology of hair and nail. In: Bologunia JL, Jorizzo JL, Rapini RP
(eds). Dermatology. London: Mosby, 2003; p 1007–1032
Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response
against melanogenesis-related proteins, exposed by abnormal MHC
class I expression in the anagen hair bulb? Yale J Biol Med 66:541–554,
1994
Paus R, van der Veen C, Eichmuller S, Kopp T, Hagen E, Muller-Rover S, Hof-
mann U: Generation and cyclic remodelling of the hair follicle immune
system in mice. J Invest Dermatol 111:7–18, 1998
IMMUNOLOGY OF THE HUMAN NAIL APPARATUS 1147125 : 6 DECEMBER 2005
Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger
JL: Protection from natural killer cell-mediated lysis by HLA-G expression
on target cells. Science 274:792–795, 1996
Picardo M, Tosti A, Marchese C, Zompetta C, Torrisi MR, Faggioni A, Cameli N:
Characterization of cultured nail matrix cells. J Am Acad Dermatol
30:434–440, 1994
Quan T, He T, Kang S, Voorhees JJ, Fisher GJ: Connective tissue growth factor:
Expression in human skin in vivo and inhibition by ultraviolet irradiation. J
Invest Dermatol 118:402–408, 2002
Rajagopalan S, Long EO: A human histocompatibility leukocyte antigen (HLA)-G-
specific receptor expressed on all natural killer cells. J Exp Med 189:
1093–1100, 1999
Rockwell PG: Acute and chronic paronychia. Am Fam Physician 63:1113–1116,
2001
Roth KA, Adler K, Bobrow MN: 9-Enhanced tyramide signal amplification
immunohistochemical detection. J Histochem Cytochem 47:1644–1645,
1999
Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED: The
alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by
natural killer cells: Is HLA-G the public ligand for natural killer cell inhib-
itory receptors? Proc Natl Acad Sci USA 94:5249–5254, 1997
Rowden G: Macrophages and dendritic cells in the skin. In: Bos JD (ed). Skin
Immune System. Boca Raton: CRC Press, 1997; p 109–146
Rudman SM, Philpott MP, Thomas GA, Kealey T: The role of IGF-I in human skin
and its appendages: Morphogen as well as mitogen? J Invest Dermatol
109:770–7, 1997
Shimizu T, Ohkawara A, Nishihira J, Sakamoto W: Identification of macrophage
migration inhibitory factor (MIF) in human skin and its immmunohisto-
chemical localization. FEBS Lett 381:199–202, 1996
Slominski A, Wortsman J, Luger T, Paus R, Solomon S: Corticotropin releasing
hormone and proopiomelanocortin involvement in the cutaneous re-
sponse to stress. Physiol Rev 80:979–1020, 2000
Slominski A, Wortsman J, Mazurkiewicz JE, et al: Detection of proopiomelanocor-
tin-derived antigens in normal and pathologic human skin. J Lab Clin Med
122:658–666, 1993
Soilleux EJ, Coleman N: Langerhans cells and the cells of Langerhans cell his-
tiocytosis do not express DC-SIGN. Blood 98:1987–1988, 2001
Streilein JW: Immune privilege as the result of local tissue barriers and immuno-
suppressive microenvironments. Curr Opin Immunol 5:428–432, 1993
Streilein JW: Ocular immune privilege: Therapeutic opportunities from an exper-
iment of nature. Nat Rev Immunol 3:879–889, 2003
Tang L, Bernardo O, Bolduc C, Lui H, Madani S, Shapiro J: The expression of
insulin-like growth factor 1 in follicular dermal papillae correlates with
therapeutic efficacy of finasteride in androgenetic alopecia. J Am Acad
Dermatol 49:229–233, 2003
Taylor AW: Ocular immunosuppressive microenvironment. Chem Immunol 73:72–
89, 1999
Tobin DJ, Paus R: Graying gerontobiology of the hair follicle pigmentary unit. Exp
Gerontol 36:29–54, 2001
Tosti A, Baran R, Dawber RPR: The nail in systemic diseases and drug-induced
changes. In: Baran R, Dawber RPR, de Berker DAR, Haneke E, Tosti A
(eds). Disease of the Nails and their Management. Oxford: Blackwell Sci-
ence, 2001; p 223–229
Tosti A, Bardazzi F, Piraccini BM, Fanti PA, Cameli N, Pileri S: Is trachyonychia, a
variety of alopecia areata, limited to the nails? J Invest Dermatol 104:27S–
28S, 1995
Tosti A, Cameli N, Piraccini BM, Fanti PA, Ortonne JP: Characterization of nail
melanocytes with anti-PEP1, anti-PEP8, TMH-1, and HMB-45 antibodies.
J Am Acad Dermatol 31:193–196, 1994
Tosti A, Fanti A, Morelli R, Bardazzi F: Trachyonychia associated with alopecia
areata: A clinical and pathologic study. J Am Acad Dermatol 25:266–270,
1991
Tosti A, Peluso AM, Fanti PA, Piraccini BM: Nail lichen planus: Clinical and patho-
logic study of twenty-four patients. J Am Acad Dermatol 28:724–730, 1993
Tosti A, Piraccini BM: Biology of nails. In: Freedberg IM, Eisen AZ, Wolff K, Frank
Austen K, Goldsmith LA, Stephen K (eds). Fitspatrick’s Dermatology in
General Medicine. New York: McGraw-Hill, 2003; p 159–163
Weetman AP: The immunology of pregnancy. Thyroid 9:643–646, 1999
Wu P, Hou L, Plikus M, Hughes M, et al: Evo-Devo of amniote integuments and
appendages. Int J Dev Biol 48:249–270, 2004
1148 ITO ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
